Issue Position: Healthcare

Issue Position

No one should have to choose between health care coverage and financial security. Rosa knows that health care reform is a smart investment, not just for our health, but for our economic well-being. She is proud to have supported the historic Affordable Care Act, and she is committed to continuing the fight to secure quality, affordable health care for every American. The Affordable Care Act is good for the middle class, for small businesses and for the economy, and we are a better and stronger country because of it. It ensures that Americans have access to quality, affordable health care while reducing the long-term costs of health coverage. The Affordable Care Act ended the power insurance companies yield over doctors and patients and over responsible and working Americans. Middle class Americans no longer have to fear being dropped by their insurance companies when they need it most. Health care reform also improves Medicare and provides prescription drug coverage seniors need. These reforms extend the life of Medicare and begin to fill the doughnut hole in coverage that leaves so many seniors vulnerable.

Being a woman is no longer a pre-existing condition. Rosa fought passionately to provide for the health needs of women in this health care reform, and all American women will gain from this fight. No longer are insurance companies allowed to treat having had a child or a c-section, or being the victim of domestic violence, as a "pre-existing condition," nor can they continue to charge individual women up to 50 percent more for the same coverage

A 30-year survivor of ovarian cancer, Rosa is also a leading advocate for funding biomedical research, including studies supported by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC). She works with colleagues to raise awareness of the need to invest in this work to save lives. This research is also critical to job growth, as every $1 invested in the NIH has been found to result in an additional $2 of business activity. This includes research supported by the NIH, surveillance supported by the CDC, grants that support graduate and professional school education, and numerous other critical programs.

Source